Imaging CAR T-cell kinetics in solid tumors: Translational implications

Albelda, 2020, Tumor antigen heterogeneity: the “elephant in the room” of adoptive T-cell therapy for solid tumors, Cancer Immunol. Res., 8, 2, 10.1158/2326-6066.CIR-19-0801 Morello, 2016, Mesothelin-targeted CARs: driving T cells to solid tumors, Cancer Discov., 6, 133, 10.1158/2159-8290.CD-15-0583 Hu, 2020, The chimeric antigen receptor detection toolkit, Front. Immunol., 11, 1770, 10.3389/fimmu.2020.01770 Ribas, 2018, Cancer immunotherapy using checkpoint blockade, Science, 359, 1350, 10.1126/science.aar4060 Grosser, 2019, Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors, Cancer Cell, 36, 471, 10.1016/j.ccell.2019.09.006 Cherkassky, 2016, Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition, J. Clin. Invest., 126, 3130, 10.1172/JCI83092 Seymour, 2017, iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics, Lancet Oncol., 18, e143, 10.1016/S1470-2045(17)30074-8 Schwartz, 2016, RECIST 1.1-update and clarification: from the RECIST committee, Eur. J. Cancer, 62, 132, 10.1016/j.ejca.2016.03.081 Wolchok, 2009, Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria, Clin. Cancer Res., 15, 7412, 10.1158/1078-0432.CCR-09-1624 Gettinger, 2015, Overall survival and long-term safety of nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer, J. Clin. Oncol., 33, 2004, 10.1200/JCO.2014.58.3708 Fujimoto, 2019, Pseudoprogression in previously treated patients with non–small cell lung cancer who received nivolumab monotherapy, J. Thorac. Oncol., 14, 468, 10.1016/j.jtho.2018.10.167 Forde, 2018, Neoadjuvant PD-1 blockade in resectable lung cancer, N. Engl. J. Med., 378, 1976, 10.1056/NEJMoa1716078 Morgan, 2010, Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2, Mol. Ther., 18, 843, 10.1038/mt.2010.24 Mulazzani, 2019, Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice, Proc. Natl. Acad. Sci. USA, 116, 24275, 10.1073/pnas.1903854116 Chekmasova, 2010, Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen, Clin. Cancer Res., 16, 3594, 10.1158/1078-0432.CCR-10-0192 Adusumilli, 2014, Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity, Sci. Transl. Med., 6, 261ra151, 10.1126/scitranslmed.3010162 Katz, 2015, Phase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor-modified t-cell therapy for CEA+ liver metastases, Clin. Cancer Res., 21, 3149, 10.1158/1078-0432.CCR-14-1421 Adusumilli, 2019, Abstract CT036. A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: safety and efficacy, Cancer Res., 79, CT036, 10.1158/1538-7445.AM2019-CT036 Adusumilli, 2019, Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: safety and preliminary efficacy in combination with anti-PD-1 agent, J. Clin. Oncol., 37, 2511, 10.1200/JCO.2019.37.15_suppl.2511 Priceman, 2018, Regional delivery of chimeric antigen receptor-engineered T cells effectively targets HER2+ breast cancer metastasis to the brain, Clin. Cancer Res., 24, 95, 10.1158/1078-0432.CCR-17-2041 Murad, 2018, Effective targeting of TAG72+ peritoneal ovarian tumors via regional delivery of CAR-engineered T cells, Front. Immunol., 9, 2268, 10.3389/fimmu.2018.02268 England, 2017, Preclinical pharmacokinetics and biodistribution studies of 89Zr-labeled pembrolizumab, J. Nucl. Med., 58, 162, 10.2967/jnumed.116.177857 Tavaré, 2015, Immuno-PET of murine T cell reconstitution postadoptive stem cell transplantation using anti-CD4 and anti-CD8 cys-diabodies, J. Nucl. Med., 56, 1258, 10.2967/jnumed.114.153338 Bensch, 2018, 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer, Nat. Med., 24, 1852, 10.1038/s41591-018-0255-8 Servais, 2012, Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients, Clin. Cancer Res., 18, 2478, 10.1158/1078-0432.CCR-11-2614 Kachala, 2014, Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma, Clin. Cancer Res., 20, 1020, 10.1158/1078-0432.CCR-13-1862 Rabinovich, 2008, Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer, Proc. Natl. Acad. Sci. USA, 105, 14342, 10.1073/pnas.0804105105 Kiesgen, 2018, Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies, J. Thorac. Oncol., 13, 16, 10.1016/j.jtho.2017.10.001 Servais, 2011, Animal models and molecular imaging tools to investigate lymph node metastases, J. Mol. Med. (Berl.), 89, 753, 10.1007/s00109-011-0764-0 Savoldo, 2011, CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients, J. Clin. Invest., 121, 1822, 10.1172/JCI46110 Hocine, 2020, Commentary: long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice, Front. Immunol., 11, 1503, 10.3389/fimmu.2020.01503 Wang, 2016, Clinical manufacturing of CAR T cells: foundation of a promising therapy, Mol. Ther. Oncolytics, 3, 16015, 10.1038/mto.2016.15 Sadelain, 2013, The basic principles of chimeric antigen receptor design, Cancer Discov., 3, 388, 10.1158/2159-8290.CD-12-0548 Wang, 2012, Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale, J. Immunother., 35, 689, 10.1097/CJI.0b013e318270dec7 Emami-Shahri, 2018, Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells, Nat. Commun., 9, 1081, 10.1038/s41467-018-03524-1 Santos, 2009, Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase, Nat. Med., 15, 338, 10.1038/nm.1930 Minn, 2019, Imaging CAR T cell therapy with PSMA-targeted positron emission tomography, Sci. Adv., 5, eaaw5096, 10.1126/sciadv.aaw5096 Haddad, 2015, Molecular imaging of oncolytic viral therapy, Mol. Ther. Oncolytics, 1, 14007, 10.1038/mto.2014.7 Gil, 2008, Utility of a herpes oncolytic virus for the detection of neural invasion by cancer, Neoplasia, 10, 347, 10.1593/neo.07981 Walters, 2013, Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens, PLoS ONE, 8, e77065, 10.1371/journal.pone.0077065 Doubrovin, 2004, Multimodality in vivo molecular-genetic imaging, Bioconjug. Chem., 15, 1376, 10.1021/bc0498572 Koehne, 2003, Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes, Nat. Biotechnol., 21, 405, 10.1038/nbt805 Lee, 2017, Comparative analysis of human nucleoside kinase-based reporter systems for PET imaging, Mol. Imaging Biol., 19, 100, 10.1007/s11307-016-0981-6 Gasser, 2005, Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation, Blood, 106, 3718, 10.1182/blood-2005-04-1366 Brodovitch, 2013, T lymphocytes sense antigens within seconds and make a decision within one minute, J. Immunol., 191, 2064, 10.4049/jimmunol.1300523 Mikucki, 2015, Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints, Nat. Commun., 6, 7458, 10.1038/ncomms8458 Uehara, 2017, Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb, Biochem. Biophys. Res. Commun., 490, 521, 10.1016/j.bbrc.2017.06.072 Vilgelm, 2019, Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy, Front. Immunol., 10, 333, 10.3389/fimmu.2019.00333 Galeano Niño, 2020, Cytotoxic T cells swarm by homotypic chemokine signalling, eLife, 9, e56554, 10.7554/eLife.56554 Moser, 2004, Chemokines: multiple levels of leukocyte migration control, Trends Immunol., 25, 75, 10.1016/j.it.2003.12.005 Lee, 2020, Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging, PLoS ONE, 15, e0223814, 10.1371/journal.pone.0223814 Dobrenkov, 2008, Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging, J. Nucl. Med., 49, 1162, 10.2967/jnumed.107.047324 Wang, 2020, Comprehensive analysis of the tumor microenvironment in cutaneous melanoma associated with immune infiltration, J. Cancer, 11, 3858, 10.7150/jca.44413 Kudo, 2019, Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer, Ann. Oncol., 30, 1521, 10.1093/annonc/mdz207 Chaft, 2016, Adaptive neoadjuvant chemotherapy guided by (18)F-FDG PET in resectable non-small cell lung cancers: the NEOSCAN trial, J. Thorac. Oncol., 11, 537, 10.1016/j.jtho.2015.12.104 Dimou, 2016, Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective, J. Thorac. Imaging, 31, 238, 10.1097/RTI.0000000000000219 Krekorian, 2019, Imaging of T-cells and their responses during anti-cancer immunotherapy, Theranostics, 9, 7924, 10.7150/thno.37924 Mezzanotte, 2017, In vivo molecular bioluminescence imaging: new tools and applications, Trends Biotechnol., 35, 640, 10.1016/j.tibtech.2017.03.012 Moroz, 2015, Comparative analysis of t cell imaging with human nuclear reporter genes, J. Nucl. Med., 56, 1055, 10.2967/jnumed.115.159855 Knorr, 2013, Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy, Stem Cells Dev., 22, 1861, 10.1089/scd.2012.0608 Kleinovink, 2019, A dual-color bioluminescence reporter mouse for simultaneous in vivo imaging of t cell localization and function, Front. Immunol., 9, 3097, 10.3389/fimmu.2018.03097 Blasberg, 2002, PET imaging of gene expression, Eur. J. Cancer, 38, 2137, 10.1016/S0959-8049(02)00390-8 Hall, 2018, 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma, Nucl. Med. Commun., 39, 161, 10.1097/MNM.0000000000000789 Yaghoubi, 2009, Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma, Nat. Clin. Pract. Oncol., 6, 53, 10.1038/ncponc1278 Keu, 2017, Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma, Sci. Transl. Med., 9, eaag2196, 10.1126/scitranslmed.aag2196 McCracken, 2015, Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging, J. Clin. Invest., 125, 1815, 10.1172/JCI77326 Likar, 2010, A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs, J. Nucl. Med., 51, 1395, 10.2967/jnumed.109.074344 Alam, 2018, Imaging activated T cells predicts response to cancer vaccines, J. Clin. Invest., 128, 2569, 10.1172/JCI98509 Doubrovin, 2007, In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene, Cancer Res., 67, 11959, 10.1158/0008-5472.CAN-07-1250 Moroz, 2007, Imaging hNET reporter gene expression with 124I-MIBG, J. Nucl. Med., 48, 827, 10.2967/jnumed.106.037812 Vedvyas, 2016, Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors, JCI Insight, 1, e90064, 10.1172/jci.insight.90064 Bhatnagar, 2013, Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64, Integr. Biol., 5, 231, 10.1039/c2ib20093g Pittet, 2007, In vivo imaging of T cell delivery to tumors after adoptive transfer therapy, Proc. Natl. Acad. Sci. USA, 104, 12457, 10.1073/pnas.0704460104 Bernhard, 2008, Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer, Cancer Immunol. Immunother., 57, 271, 10.1007/s00262-007-0355-7 Grimfors, 1989, Tumour imaging of indium-111 oxine-labelled autologous lymphocytes as a staging method in Hodgkin’s disease, Eur. J. Haematol., 42, 276, 10.1111/j.1600-0609.1989.tb00112.x Fisher, 1989, Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma, J. Clin. Oncol., 7, 250, 10.1200/JCO.1989.7.2.250 Krebs, 2018, Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes, J. Nucl. Med., 59, 1894, 10.2967/jnumed.118.208041